J.R. & Inez Jay Fund

group of researchers working together

The J.R. & Inez Jay Fund is an endowed fund at the KU Endowment Association that was established by the Jay’s to encourage the conduct of biomedical research. The purpose of the J.R. and Inez Jay Award is to stimulate interdisciplinary, biomedical research activities, in pursuit of large external grants such as multi-investigator R01 awards, program projects, and center grants awarded under the tutelage of the HBC. To that end, recipients may use Jay funding to gather preliminary data, hire temporary staff, travel to collaborators’ labs, write major grant proposals, and secure supplies and services that enhance those proposals. The HBC conducts an annual call for proposals. Generally two proposals are granted annually, with one of the awards targeted to a early career investigator. All biomedical scientists holding Principal Investigator status at KU are eligible to apply for one of these awards. The emphasis of the awards is strongly on interdisciplinary, collaborative research efforts.

Eligibility:Applicants must hold Principal Investigator status with Kansas University Center for Research, Inc. (KUCR).

Purpose: To stimulate interdisciplinary, biomedical research activities that lead to large-scale research activities such as multi-investigator R01 awards, program projects, and center grants administered through the Higuchi Biosciences Center.

Application Procedure: Proposals will take the form of a prospectus and must be submitted with the required forms docx listed below:

  • Cover Page (which includes abstract)
  • Research Narrative (no more than 2 additional pages.)
  • Budget
  • Investment potential

Please review the detailed instructions pdf before submitting your application.

The prospectus should:

  • Outline the nature of the proposed project and how it will enhance the research mission of the Higuchi Biosciences Center.
  • Outline the specific plans for submitting new or revised applications for multi-investigator R01 grants, program projects, center grants, or other large multidisciplinary efforts.
  • Clearly indicate a timetable for acquisition of external funding and an analysis of the likelihood of success.

Application deadlineThe application deadline for year 2021 has passed.  New applications will be accepted in Late January of 2022.

Evaluation Criteria:.

  • The proposal must be for biomedical research and seeks to advance specific thematic areas per the stated mission of NIH.
  • The proposal must be interdisciplinary in approach, preferably structured so that a multi-investigator R01, program project, or center grant proposal to an external funding agency will result from the Jay Fund.
  • The proposal should describe explicitly the steps already taken towards the completion of a multidisciplinary grant proposal to external funding agencies.
  • The project must be likely to secure continuing outside funding for a large multidisciplinary grant program, as described above, with commensurate indirect costs that can be reinvested in other projects.
  • The proposal should describe the specific work to be undertaken during the term of the award.

The Review Committee will select proposals that represent the best investment opportunities from those that meet the criteria listed above.

For clarification or additional information please call John Stobaugh 785-864-3996 or Nicole Suchy 785-864-3572.


Summary of Awards
Michael Johnson "Light-Initiated Zinc Signaling in Parkinson’s disease" $25,000 
William Picking "Applying novel approaches to obtain the molecular structures of difficult T3SS proteins" $25,000 
Shyam Sathyamoorthi "Development of New Antibacterial Agents: A Synthesis of the Antibiotic Enacyloxin IIa for the Generation of Therapeutic Analogues" $25,000 
Mike Hageman  "Translation of Injectable-to-Oral Pharmacotherapy: Application of E- Cadherin Binding Peptides as Oral Permeation Enhancers" $20,000 
Frank Schoenen  "Design, synthesis, analytical characterization, eAMDE, formulation, sub-chronic MTD and in vivo PK of ML329 Prodrugs" $20,000 
Jingxing Wang  "Mechanistic study of RNA splicing modulation by small molecules" $20,000 
Mark P. Farrell and Adam Smith "Sugar coated vaccines for the treatment of opioid use disorder" $30,000 
Mark Richter "Continuous monitoring of histamine in the brain" $30,000 
Josephine Chandler "Blocking quorum sensing to potentiate antibiotics in Pseudomonas aeruginosa" $30,000 
Kristi Neufeld "Novel function of APC tumor suppressor in DNA Topoisomerase II-mediated cell cycle checkpoint" $30,000 
Wendy Picking "Development of a vaccine to help cystic fibrosis patients" $30,000 
Michael Wang "Blood Exosomal Drug-Metabolizing Enzymes for Individualized Medicine" $30,000 
Liqin Zhao "ApoE2 as a therapeutic shield against Alzheimer’s disease: a proof-of-concept study" $30,000 

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today